Structure of Apixaban CAS 503612-47-3

Apixaban CAS 503612-47-3

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

503612-47-3

Name

Apixaban

Synonyms

1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid [German] [ACD/IUPAC Name]
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide [ACD/IUPAC Name]
1-(4-Méthoxyphényl)-7-oxo-6-[4-(2-oxo-1-pipéridinyl)phényl]-4,5,6,7-tétrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide [French] [ACD/IUPAC Name]
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]- [ACD/Index Name]
503612-47-3 [RN]
Apixaban [INN] [USAN] [Wiki]
apixabanum [Latin] [INN]
BMS 562247-01
[503612-47-3]
1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide
1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-; 3-carboxylic acid amide
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
205-514-0 [EINECS]
4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
Apixaban (USAN/INN)
apixabanum
BMS-562247|Eliquis®
BMS562247-01
Eliquis [Trade name]
Eliquis®
GG2
MFCD00002708 [MDL number]
MFCD11977295 [MDL number]
OO 1750000
UNII-3Z9Y7UWC1J

Molecular Structure

Structure of Apixaban CAS 503612-47-3

Structure of Apixaban CAS 503612-47-3

SMILES

COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N

StdInChI

InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)

StdInChIKey

QNZCBYKSOIHPEH-UHFFFAOYSA-N

Molecular Formula

C25H25N5O4

Molecular Weight

459.50

EINECS

205-514-0

MDL Number

MFCD00002708

Properties

Appearance

White powder

Specifications and Other Information of Our Apixaban CAS 503612-47-3

Standard

Enterprise standard

GMP

LCFDA

Basic Patent Situation

US expiry date20230203
EU expiry date20260517
JP expiry date2026818

Identification Methods

HNMR/HPLC

Purity

98%min

Storage

Under the room temperature and away from light

Application

Used as the pharmaceutical API, primary prevention of thrombin generation and thrombus formation.

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/apixaban-cas-503612-47-3/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/apixaban-cas-503612-47-3/